Tuesday 26 May 2015

Name your topics of interest


This time, I plan to collect interesting updates per topic- in addition to single updates- so if you had particular areas of interest, please add them under comments here!

Nothing promised but I'll do my best :-)

For very specific questions- e.g. regarding a single new drug or the follow up of a basic research paper you've seen- please check the ASCO abstracts here first.

And please should you find anything of relevance in the abstracts/ ASCO documentation online that you feel the wider Melanoma community should read, please directly comment on the relevant post or the extra post 'Noteworthy ASCO findings'.


Topics planned so far-


  • Acquired resistance to targeted therapy
  • Combination of Ipi and PD1
  • Adjuvant options for Stage 3 Melanoma



Posted by at

5 comments:

  1. Violeta Astratinei26 May 2015 at 07:45

    Combinations of targeted therapies and imunotherapies
    Management of brain tumours
    Latest vaccine developments

    ReplyDelete
  2. Gilliosa SB27 May 2015 at 00:11

    drug sequences and combinations (Tvec-Pembro) and changes to clinical trials design ??

    ReplyDelete
  3. Violeta Astratinei28 May 2015 at 00:26

    Triple combination Dabrafenib,Trametinib and anti-PDL1 (MEDI4736).

    ReplyDelete
  4. Gilliosa SB29 May 2015 at 06:15

    the age old question of Interferon as adjuvant - is it worth it

    ReplyDelete
  5. Unknown30 May 2015 at 14:18

    T-vec and combinations with immunotherapy:
    http://abstracts.asco.org/156/AbstView_156_151884.html
    http://abstracts.asco.org/156/AbstView_156_144668.html

    ReplyDelete

Subscribe to: Post Comments (Atom)